Abstract
Tumoral necrosis factor alpha blockers are very efficient in the treatment of many inflammatory systemic diseases, including rheumatoid arthritis and psoriasis. However, a paradoxical arouse of psoriasiform lesions may occur in a few patients taking anti-TNFα. The etiology of this rare side effect is still a mystery, and its treatment may be difficult. The authors report the resolution of adalimumab-induced psoriasis in a woman with rheumatoid arthritis after the use of high vitamin D3 doses for the treatment of vitamin D deficiency. This is the first report of resolution of anti-TNFα-induced psoriasiform lesions by high doses of vitamin D3 in a patient with rheumatoid arthritis and vitamin D deficiency. This case raises interesting questions on the role of vitamin D deficiency in the pathogenesis of this side effect and on the possible usefulness of high-dose vitamin D3 in its treatment.
Similar content being viewed by others
References
Wollina U, Hansel G, Koch A, Schönlebe J, Köstler E, Haroske G. (2008) Tumor necrosis factor-[alpha] inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol 9(1). Available from: http://adisonline.com/dermatology/Fulltext/2008/09010/Tumor_Necrosis_Factor__alpha__Inhibitor_Induced.1.aspx. [Internet]
Harrison MJ, Dixon WG, Watson KD, King Y, Groves R, Hyrich KL et al (2009) Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis Fev 68(2):209–215
Fouache D, Goëb V, Massy-Guillemant N, Avenel G, Bacquet-Deschryver H, Kozyreff-Meurice M et al (2009) Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study. Rheumatology (Oxford) 48(7):761–764
de Gannes GC, Ghoreishi M, Pope J, Russell A, Bell D, Adams S et al (2007) Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol 143(2):223–231
Grinblat B, Scheinberg M (2008) The enigmatic development of psoriasis and psoriasiform lesions during anti-TNF therapy: a review. Semin Arthr Rheum 37(4):251–255
Seneschal J, Milpied B, Vergier B, Lepreux S, Schaeverbeke T, Taïeb A (2009) Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments. Br J Dermatol 161(5):1081–1088
Adams JS, Hewison M (2010) Update in vitamin D. J Clin Endocrinol Metab 95(2):471–478
Tanghetti EA (2009) The role of topical vitamin D modulators in psoriasis therapy. J Drugs Dermatol 8(8 Suppl):s4–s8
Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66(9):1137–1142
Prabhu Anand S, Selvaraj P, Narayanan PR (2009) Effect of 1, 25 dihydroxyvitamin D3 on intracellular IFN-gamma and TNF-alpha positive T cell subsets in pulmonary tuberculosis. Cytokine 45(2):105–110
Dayangac-Erden D, Karaduman A, Erdem-Yurter H (2007) Polymorphisms of vitamin D receptor gene in Turkish familial psoriasis patients. Arch Dermatol Res 299(10):487–491
Okita H, Ohtsuka T, Yamakage A, Yamazaki S (2002) Polymorphism of the vitamin D(3) receptor in patients with psoriasis. Arch Dermatol Res 294(4):159–162
Perez A, Raab R, Chen TC, Turner A, Holick MF (1996) Safety and efficacy of oral calcitriol (1, 25-dihydroxyvitamin D3) for the treatment of psoriasis. Br J Dermatol 134(6):1070–1078
Huckins D, Felson DT, Holick M (1990) Treatment of psoriatic arthritis with oral 1, 25-dihydroxyvitamin D3: a pilot study. Arthr Rheum 33(11):1723–1727
Gaál J, Lakos G, Szodoray P, Kiss J, Horváth I, Horkay E et al (2009) Immunological and clinical effects of alphacalcidol in patients with psoriatic arthropathy: results of an open, follow-up pilot study. Acta Derm Venereol 89(2):140–144
Conflict of interest
The authors declare no potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Werner de Castro, G.R., Neves, F.S., Pereira, I.A. et al. Resolution of adalimumab-induced psoriasis after vitamin D deficiency treatment. Rheumatol Int 32, 1313–1316 (2012). https://doi.org/10.1007/s00296-011-1799-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-1799-9